Dr. Reddys Laboratories Ltd.

A decent increase of about 33.70% in the sales to Rs. 78095.00 millions was observed for the quarter ended June 2025. The sales figure stood at Rs. 58412.00 millions during the year-ago period.The Net Profit of the company vaulted to 108.95% to Rs. 29612.00  millions from Rs. 14172.00 millions in the previous quarter.The company reported a good operating profit of 42353.00 millions compared to 21708.00 millions of corresponding previous quarter.

(Rs. in Million)

	Quarter ended			Year to Date			Year ended
	202506	202406	% Var	202506	202406	% Var	202503	202403	% Var
Sales	78095.00	58412.00	33.70	78095.00	58412.00	33.70	231154.00	194838.00	18.64
Other Income	3983.00	2178.00	82.87	3983.00	2178.00	82.87	10034.00	8623.00	16.36
PBIDT	42353.00	21708.00	95.10	42353.00	21708.00	95.10	83852.00	67887.00	23.52
Interest	192.00	71.00	170.42	192.00	71.00	170.42	1099.00	218.00	404.13
PBDT	42161.00	21637.00	94.86	42161.00	21637.00	94.86	82753.00	67669.00	22.29
Depreciation	2798.00	2498.00	12.01	2798.00	2498.00	12.01	10394.00	9756.00	6.54
PBT	39363.00	19139.00	105.67	39363.00	19139.00	105.67	72359.00	57913.00	24.94
TAX	9751.00	4967.00	96.32	9751.00	4967.00	96.32	18865.00	14493.00	30.17
Deferred Tax	334.00	301.00	10.96	334.00	301.00	10.96	960.00	875.00	9.71
PAT	29612.00	14172.00	108.95	29612.00	14172.00	108.95	53494.00	43420.00	23.20
Equity	835.00	834.00	0.12	835.00	834.00	0.12	834.00	834.00	0.00
PBIDTM(%)	54.23	37.16	45.93	54.23	37.16	45.93	36.28	34.84	4.11